Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

Inclusion Criteria:

1. Participant provides written informed consent (participant, parent or legal guardian
and, as appropriate, informed assent) to participate in the study before completing
any study-related procedures.

2. Participant completed the TED-C14-006 or SHP633-301 studies (including participants in
the standard of care treatment arms). Participants are considered to have completed
SHP633-301 if they completed study assessments through week 24.

3. Participant understands and is willing and able to fully adhere to study requirements
as defined in this protocol.

Exclusion Criteria:

1. There are no exclusion criteria for this study.